|
FEM1B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.817900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.550400E-01 |
| Normal-vs-Stage2 |
8.310000E-02 |
| Normal-vs-Stage3 |
1.72620000005175E-06 |
| Normal-vs-Stage4 |
1.51780999999573E-05 |
| Stage1-vs-Stage2 |
2.377000E-01 |
| Stage1-vs-Stage3 |
1.032060E-04 |
| Stage1-vs-Stage4 |
1.018710E-04 |
| Stage2-vs-Stage3 |
1.581160E-01 |
| Stage2-vs-Stage4 |
7.796300E-02 |
| Stage3-vs-Stage4 |
5.407600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.144730E-03 |
| Normal-vs-AfricanAmerican |
2.740100E-03 |
| Normal-vs-Asian |
6.880000E-01 |
| Caucasian-vs-AfricanAmerican |
2.674600E-01 |
| Caucasian-vs-Asian |
5.879600E-01 |
| AfricanAmerican-vs-Asian |
3.297600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.956170E-04 |
| Normal-vs-Female |
4.677800E-02 |
| Male-vs-Female |
1.146970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.842300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.523800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.200700E-04 |
| Normal-vs-Age(81-100Yrs) |
1.667890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.577800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.431000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.437600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.108000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.105000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.882400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.666200E-01 |
| Normal-vs-Grade 2 |
3.772200E-01 |
| Normal-vs-Grade 3 |
7.98610000000144E-05 |
| Normal-vs-Grade 4 |
1.08330000525569E-09 |
| Grade 1-vs-Grade 2 |
4.727200E-01 |
| Grade 1-vs-Grade 3 |
5.230100E-02 |
| Grade 1-vs-Grade 4 |
2.758300E-04 |
| Grade 2-vs-Grade 3 |
1.060230E-03 |
| Grade 2-vs-Grade 4 |
1.12079999725623E-08 |
| Grade 3-vs-Grade 4 |
3.335800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.631800E-01 |
| Normal-vs-ccB subtype |
6.228900E-04 |
| ccA subtype-vs-ccB subtype |
5.412300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.824900E-03 |
| Normal-vs-N1 |
4.556000E-02 |
| N0-vs-N1 |
2.097000E-01 |
|
|
